Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer?

World Journal of Gastroenterology

Volumn 15, Issue 34, 2009, Pages 4290-4297

  Mabe, Katsuhiro ^a   Takahashi, Mikako ^b   Oizumi, Haruhumi ^c   Tsukuma, Hideaki ^d   Shibata, Akiko ^e   Fukase, Kazutoshi ^f   Matsuda, Toru ^g   Takeda, Hiroaki ^h   Kawata, Sumio ^h  

^a KKR Sapporo Medical Center   (Japan)

^b Tsuruoka Kyoritsu Hospital   (Japan)

^c Oizumi Medical Clinic   (Japan)

^d OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^e Division of Cancer Control   (Japan)

^f Yamagata Prefectural Central Hospital   (Japan)

^g Yamagata Prefectural Shonai Public Health Center   (Japan)

^h YAMAGATA UNIVERSITY   (Japan)

Author keywords

Cancer prevention; Eradication therapy; Gastric cancer; Helicobacter pylori; Peptic ulcer

Indexed keywords

AMOXICILLIN; ANTACID AGENT; CLARITHROMYCIN; LANSOPRAZOLE; OMEPRAZOLE; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ANTIINFECTIVE AGENT; ANTIULCER AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PREVENTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DUODENUM ULCER; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PEPTIC ULCER; PRIMARY PREVENTION; STOMACH CANCER; STOMACH CARCINOGENESIS; TREATMENT FAILURE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; STOMACH TUMOR;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; FEMALE; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PEPTIC ULCER; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 70349579097     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.4290     Document Type: Article

References (15)

1. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer Incidence in Five Continents, Vol.VIII IARC Scientific Publications No.155. Lyon: IARC, 2002
2. Infection with Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans. Vol.61. Schistosomes, liver flukes and Helicobacter pylori. Lyon: International Agency for Research on Cancer, 1994: 177-241
3. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789 (Pubitemid 34940841)
4. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 1998; 115: 642-648 (Pubitemid 28397299)
5. Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res 1998; 58: 4255-4259
6. Hirayama F, Takagi S, Iwao E, Yokoyama Y, Haga K, Hanada S. Development of poorly differentiated adenocar c inoma and car c inoid due to long- t e rm Helicobacter pylori colonization in Mongolian gerbils. J Gastroenterol 1999; 34: 450-454 (Pubitemid 29408169)
7. Nozaki K, Shimizu N, Ikehara Y, Inoue M, Tsukamoto T, Inada K, Tanaka H, Kumagai T, Kaminishi M, Tatematsu M. Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils. Cancer Sci 2003; 94: 235-239 (Pubitemid 36575888)
8. Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K, Oguma K, Okada H, Shiratori Y. The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol 2005; 100: 1037-1042 (Pubitemid 40769039)
9. Kamada T, Hata J, Sugiu K, Kusunoki H, Ito M, Tanaka S, Inoue K, Kawamura Y, Chayama K, Haruma K. Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan. Aliment Pharmacol Ther 2005; 21: 1121-1126 (Pubitemid 40646538)
10. Takenaka R, Okada H, Kato J, Makidono C, Hori S, Kawahara Y, Miyoshi M, Yumoto E, Imagawa A, Toyokawa T, Sakaguchi K, Shiratori Y. Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type. Aliment Pharmacol Ther 2007; 25: 805-812 (Pubitemid 46434921)
11. Ogura K, Hirata Y, Yanai A, Shibata W, Ohmae T, Mitsuno Y, Maeda S, Watabe H, Yamaji Y, Okamoto M, Yoshida H, Kawabe T, Omata M. The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer. J Clin Gastroenterol 2008; 42: 279-283 (Pubitemid 351301494)
12. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, Ching CK, Chen JS. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187-194
13. Fuccio L, Zagari RM, Minardi ME, Bazzoli F. Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer. Aliment Pharmacol Ther 2007; 25: 133-141 (Pubitemid 46046370)
14. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008; 372: 392-397
15. Honmyo U, Misumi A, Murakami A, Haga Y, Akagi M. Clinicopathological analysis of synchronous multiple gastric carcinoma. Eur J Surg Oncol 1989; 15: 316-321 (Pubitemid 19212511)